We are live on
!
Find out more
SCM
Stevens Capital Management Portfolio holdings
AUM
$649M
1-Year Est. Return
27.37%
This Fund
S&P 500
This Quarter
Est. Return
+2.44%
1 Year Est. Return
+27.37%
3 Year Est. Return
+49.81%
5 Year Est. Return
+67%
10 Year Est. Return
+208.35%
AUM
$2.24B
AUM Growth
-$107M
(-4.6%)
Cap. Flow
-$138M
Cap. Flow
% of AUM
-6.17%
Top 10 Holdings %
Top 10 Hldgs %
13.17%
Holding
955
New
308
Increased
134
Reduced
160
Closed
350
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$31.3M |
| 2 |
Merck
MRK
|
+$28.9M |
| 3 |
Morgan Stanley
MS
|
+$28.2M |
| 4 |
Verizon
VZ
|
+$27.6M |
| 5 |
Johnson & Johnson
JNJ
|
+$23.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CME Group
CME
|
+$22.4M |
| 2 |
Duke Energy
DUK
|
+$22M |
| 3 |
Cognizant
CTSH
|
+$19.2M |
| 4 |
Fidelity National Information Services
FIS
|
+$19M |
| 5 |
Eaton
ETN
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.11% |
| 2 | Healthcare | 14.85% |
| 3 | Industrials | 13.1% |
| 4 | Technology | 12.1% |
| 5 | Consumer Discretionary | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALXN
51
DELISTED
Alexion Pharmaceuticals
ALXN
| $10.1M | 0.45% |
76,820
+48,802
| +174% | +$6.29M |
|
52
Trane Technologies
TT
$106B
| $10.1M | 0.45% |
79,341
+2,425
| +3% | +$290K |
|
53
Bank of America
BAC
$435B
| $10M | 0.45% |
345,259
-461,762
| -57% | -$13.3M |
|
54
O'Reilly Automotive
ORLY
$72.4B
| $9.92M | 0.44% |
402,840
+357,690
| +792% | +$9.06M |
|
55
GoDaddy
GDDY
$12.3B
| $9.79M | 0.44% |
139,514
+50,198
| +56% | +$3.79M |
|
56
Public Service Enterprise Group
PEG
$39.8B
| $9.77M | 0.44% |
166,152
-27,283
| -14% | -$1.63M |
|
57
Altria Group
MO
$122B
| $9.75M | 0.44% |
+205,984
| New | +$10.8M |
|
58
Dover
DOV
$27.2B
| $9.61M | 0.43% |
95,879
+49,646
| +107% | +$4.76M |
|
59
Hartford Financial Services
HIG
$38.5B
| $9.46M | 0.42% |
169,812
+11,197
| +7% | +$591K |
|
60
Lamb Weston
LW
$6.82B
| $9.41M | 0.42% |
148,600
-18,787
| -11% | -$1.24M |
|
61
Verisk Analytics
VRSK
$26.4B
| $9.41M | 0.42% |
+64,240
| New | +$9.06M |
|
|
FNSR
62
DELISTED
Finisar Corp
FNSR
| $9.02M | 0.4% |
394,345
| – | – |
|
63
Amphenol
APH
$188B
| $8.99M | 0.4% |
+374,892
| New | +$9.02M |
|
64
Advance Auto Parts
AAP
$3.37B
| $8.99M | 0.4% |
+58,333
| New | +$9.47M |
|
|
FDC
65
DELISTED
First Data Corporation
FDC
| $8.8M | 0.39% |
+325,009
| New | +$8.46M |
|
66
American Tower
AMT
$77.7B
| $8.58M | 0.38% |
+41,961
| New | +$8.44M |
|
|
APC
67
DELISTED
Anadarko Petroleum
APC
| $8.55M | 0.38% |
121,120
-95,865
| -44% | -$6.43M |
|
68
Bristol-Myers Squibb
BMY
$127B
| $8.52M | 0.38% |
187,805
-39,149
| -17% | -$1.82M |
|
69
Boston Properties
BXP
$11B
| $8.43M | 0.38% |
65,311
+52,589
| +413% | +$7.06M |
|
70
Monster Beverage
MNST
$91.4B
| $8.36M | 0.37% |
261,836
-372,466
| -59% | -$11.2M |
|
71
Halliburton
HAL
$27.9B
| $8.29M | 0.37% |
364,780
+255,047
| +232% | +$6.62M |
|
|
LLL
72
DELISTED
L3 Technologies, Inc.
LLL
| $8.29M | 0.37% |
33,816
-6,650
| -16% | -$1.55M |
|
|
STI
73
DELISTED
SunTrust Banks, Inc.
STI
| $8.26M | 0.37% |
+131,413
| New | +$8.26M |
|
|
DATA
74
DELISTED
Tableau Software, Inc.
DATA
| $8.25M | 0.37% |
49,705
+32,899
| +196% | +$4.32M |
|
|
WP
75
DELISTED
Worldpay, Inc.
WP
| $8.16M | 0.37% |
+66,617
| New | +$7.9M |
|
Similar funds
CCA
HPIA
GAMA
TWP
ACA
CAAM
RK
PCM
Stevens Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Stevens Capital Management held 955 positions worth $2.24B, down 4.6% from $2.34B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Stevens Capital Management withdrew a net $138M in Q2 2019, closing 350 positions and reducing 160 holdings. Its most notable exit was Cognizant, an estimated $19.2M position sold in full.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Stevens Capital Management opened a new position in Merck worth $30.2M.
- Stevens Capital Management's largest Q2 2019 buy was Merck: 377,581 shares worth $30.2M.
- Stevens Capital Management added most to Eli Lilly in Q2 2019, an estimated $31.3M increase.
- Stevens Capital Management's biggest Q2 2019 reduction was CME Group, cutting an estimated $22.4M.
- Stevens Capital Management fully exited Cognizant in Q2 2019, selling an estimated $19.2M.
- Stevens Capital Management's ten largest holdings make up 13% of its $2.24B portfolio in Q2 2019.
- Stevens Capital Management opened 308 new positions and closed 350 in Q2 2019.
- Stevens Capital Management's portfolio value fell 4.6% quarter-over-quarter to $2.24B.
Based on Stevens Capital Management's 13F filing for Q2 2019, filed 31 Jul 2019.